ArticleCancer immunology, immunotherapy : CII2026
Low-dose IL-2 therapy for immune-related adverse events via Tfh/Treg balance modulation: a prospective cohort and murine model study.
Yifan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.